ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39551-10mg |
|
1550053-02-5 |
BRD3308
|
0 | C15H14FN3O2 | |
GC39551-10mM (in 1mL DMSO) |
|
1550053-02-5 |
BRD3308
|
0 | C15H14FN3O2 | |
GC39551-5mg |
|
1550053-02-5 |
BRD3308
|
0 | C15H14FN3O2 | |
GC39550-25mg |
|
1071661-55-6 |
Pi-Methylimidazoleacetic acid hydrochloride
|
0 | C6H9ClN2O2 | |
GC39550-10mg |
|
1071661-55-6 |
Pi-Methylimidazoleacetic acid hydrochloride
|
0 | C6H9ClN2O2 | |
GC39550-10mM (in 1mL DMSO) |
|
1071661-55-6 |
Pi-Methylimidazoleacetic acid hydrochloride
|
0 | C6H9ClN2O2 | |
GC39550-5mg |
|
1071661-55-6 |
Pi-Methylimidazoleacetic acid hydrochloride
|
0 | C6H9ClN2O2 | |
GC39549-25mg |
|
634913-39-6 |
AER-271
|
0 | C15H9ClF6NO5P | |
GC39549-10mg |
|
634913-39-6 |
AER-271
|
0 | C15H9ClF6NO5P | |
GC39549-10mM (in 1mL DMSO) |
|
634913-39-6 |
AER-271
|
0 | C15H9ClF6NO5P | |
GC39549-5mg |
|
634913-39-6 |
AER-271
|
0 | C15H9ClF6NO5P | |
GC39548-100mg |
|
64544-07-6 |
Cefuroxime axetil
|
0 | C20H22N4O10S | |
GC39548-50mg |
|
64544-07-6 |
Cefuroxime axetil
|
0 | C20H22N4O10S | |
GC39548-10mM (in 1mL DMSO) |
|
64544-07-6 |
Cefuroxime axetil
|
0 | C20H22N4O10S | |
GC39548-25mg |
|
64544-07-6 |
Cefuroxime axetil
|
0 | C20H22N4O10S | |
GC39547-100mg |
|
339-43-5 |
Carbutamide
|
0 | C11H17N3O3S | |
GC39547-50mg |
|
339-43-5 |
Carbutamide
|
0 | C11H17N3O3S | |
GC39547-10mM (in 1mL DMSO) |
|
339-43-5 |
Carbutamide
|
0 | C11H17N3O3S | |
GC39547-25mg |
|
339-43-5 |
Carbutamide
|
0 | C11H17N3O3S | |
GC39546-100mg |
|
42864-78-8 |
Bevantolol hydrochloride
|
0 | C20H28ClNO4 | |